Trial intelligence / Profile preview

Oral montelukast in hospitalized children with severe asthma exacerbation

IRCT20251021067707N1Phase 4Completed

Sponsor
Urmia University of Medical Sciences
Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of montelukast in asthma, sponsored by Urmia University of Medical Sciences. Started Nov 2025; status: completed.

02

Drugs

montelukast
03

Conditions

asthma

Beyond the preview

Go deeper on IRCT20251021067707N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20251021067707N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call